All Updates

All Updates

icon
Filter
Product updates
Know Labs launches non-invasive glucose monitor prototype
Preventive Healthcare
Jun 7, 2023
This week:
M&A
N-able acquires Adlumin for USD 266 million to strengthen cybersecurity offerings
Next-gen Cybersecurity
Today
M&A
Bitsight acquires Cybersixgill for USD 115 million to enhance threat intelligence capabilities
Cyber Insurance
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Generative AI Infrastructure
Today
M&A
Snowflake acquires Datavolo to enhance data integration capabilities for undisclosed sum
Data Infrastructure & Analytics
Today
Product updates
Microsoft launches Copilot Actions for workplace automation
Foundation Models
Yesterday
M&A
Almanac acquires Gro Intelligence's IP assets for undisclosed sum
Smart Farming
Yesterday
Partnerships
Aduro Clean Technologies partners with Zeton to build hydrochemolytic pilot plant
Waste Recovery & Management Tech
Yesterday
Funding
Oishii raises USD 16 million in Series B funding from Resilience Reserve
Vertical Farming
Yesterday
Management news
GrowUp Farms appoints Mike Hedges as CEO
Vertical Farming
Yesterday
M&A
Rise Up acquires Yunoo and expands LMS monetization capabilities
EdTech: Corporate Learning
Yesterday
Preventive Healthcare

Preventive Healthcare

Jun 7, 2023

Know Labs launches non-invasive glucose monitor prototype

Product updates

  • Passive remote monitoring company Know Labs has showcased the Generation 1 (Gen 1) Device, the next stage of its Bio-RFID technology development. The Gen 1 Device incorporates Know Labs' Bio-RFID sensor and aims to deliver the world's first FDA-cleared non-invasive blood glucose monitor for people with diabetes and pre-diabetes.

  • The Gen 1 Device is a portable research lab that collects blood glucose data for algorithm development and refinement. It features a Bio-RFID sensor and is designed to be scalable, allowing testing across diverse populations and scenarios. The device is built with advanced engineering and has onboard computing power, machine-learning capabilities, and long battery life.

  • The device allows high-quality data collection, iterative research, and the generation of large and novel datasets for algorithm optimization. The company plans to continue refining the device while working toward FDA clearance and external validation of its technology.

Contact us

Gain access to all industry hubs, market maps, research tools, and more
Get a demo
arrow
menuarrow

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.